NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMS+) Q2 2021 Earnings

9AugExpected
Q1 2021
Q2 2021
-0.07
0.01
0.08
0.16

Details

Expected EPS
N/A
Actual EPS
-0.07
Surprise EPS
-0.07
Surprise Percent
+∞%

Description

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMS+) has reported earnings of -0.07 per share for Q2 2021.

0 Comments

Share your thoughts